Medicine’s New Frontier: Clinicians and Researchers Aim To Combine Expertise With Artificial Intelligence To Improve Patients’ Lives
As UF continues to make strides in the field of AI, researchers are putting a focus on improving patient care. At the College of Medicine, these new technologies will improve patient's lives while building the foundation for new training methods to teach the next generation of physicians.
UF Opens Malachowsky Hall for Data Science & Information Technology
The University of Florida Friday held a celebratory ribbon cutting for the Malachowsky Hall for Data Science & Information Technology. The new building is named after UF alumnus and NVIDIA co-founder Chris Malachowsky, and funded by a combination of state funds as well as private and college funds.
Enhancing Kidney Care With Machine Learning Models for Dynamic and Accurate Results
Bihorac stressed the need for healthcare professionals to embrace the power of AI and deep learning models in personalized medicine. She stated that as the world moves towards using foundational AI models, healthcare professionals must actively participate in this transformation.
Making an Impact on Movement Disorders
AI applications for improving treatment for patients with movement disorders includes work by assistant professor Coralie de Hemptinne, PhD, MS, and biomedical scientist Jackson Cagle, PhD, researchers at the Norman Fixel Institute for Neurological Diseases at UF Health who have developed an algorithm to optimize deep brain stimulation, or DBS, a treatment that involves placing a thin wire in the brain in areas that control movement. Their technology, which received UF Innovate’s 2022 Invention of the Year award, predicts the best stimulation settings based on individual brain activity, shortening the wait to see improvement in symptoms.
Clinical Spotlight: UF Health Aortic Disease Center Celebrates Five Years
As of 2023, the team at UF Health's Aortic Disease Center has surpassed their 2018 goals of increasing case volume, broadening research, and improving the quality of treatment for patients. Led by Tom Martin, M.D., the center is also leveraging AI to improve the future of health care and put patients first.
Tech Tuesday: A Helpful Virus
In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Dr. Arun Srivastava from the University of Florida's College of Medicine Department of Pediatrics who introduces us to a virus -- the adeno-associated virus or AAV -- that cures rather than infects. AAV has cured nine human diseases. The FDA has approved five drugs using it. And Dr. Srivastava's lab of scientists is working to make the vectors more efficient.
Can Milk Cure COVID-19? Not Exactly, but a New Treatment Shows Promise
College of Medicine researcher Dr. David Ostrov wrote this opinion piece for The Hill after his discovery of a potential therapy or preventative for COVID became public knowledge:
“Got milk? Cure COVID” was a meme that started circulating after one of our discoveries from the University of Florida went public. It playfully highlighted a major medical milestone: We had found a combination of two over-the-counter products that could inhibit 99 percent of SARS-CoV-2 replication in human lung cells, and one of them was milk-based.
Discovery Shows How Pervasive Epstein-Barr Virus Could Be Thwarted
New, early findings by University of Florida Health researchers show how the Epstein-Barr virus’s advance could be thwarted.
BioMérieux Receives CE Mark for Biomarker Assay for Mild TBI
BioMérieux, which signed an agreement in 2017 with Banyan Biomarkers to commercialize its TBI assay, has obtained the CE Mark for its assay to detect two biomarkers associated with mild traumatic brain injury (mTBI).
Capsida Biotherapeutics Enters Strategic Collaboration With Kate Therapeutics to Manufacture KateTx’s Next-Generation Gene Therapies
Capsida Biotherapeutics Inc. and UF startup Kate Therapeutics announced a strategic partnership to leverage Capsida's expertise and adeno-associated virus (AAV) manufacturing capabilities to enable KateTx's initial internal portfolio of muscle and heart disease programs.
